Cardiovascular and Interventional Radiological Society of Europe
CIRSE Academy coursesVenous Intervention - online coursesSVC stenting for treatment of malignant obstruction (2021 – CME) – online course

SVC stenting for treatment of malignant obstruction (2021 – CME) – online course

55 | 25(for CIRSE members)

Description

Authors: A. Mahnken and H. Moriarty

Reviewers: A. Basile, V. Bérczi, B. Gebauer, S. Hopf-Jensen and C. Nice

This course corresponds to chapter 2.2.1.3.3 Disease of the Superior and Inferior Vena Cava in the European Curriculum and Syllabus for IR.

 

Abstract

Obstruction of the superior vena cava (SVC), in the modern era, occurs most frequently in malignancy, with bronchogenic carcinoma accounting for at least 50% of causes. Presentation may be as a medical emergency, with features of respiratory or CNS depression, or more indolent in nature. The severity and duration of symptoms of SVC obstruction (SVCO) are an important guide to the timing of intervention. Charnsangavej et al. in 1986 described an endovascular approach for the treatment of SVCO. Percutaneous stenting of the SVC is a minimally invasive procedure which allows rapid alleviation of symptoms without interfering with tumour treatment.

 

Learning Objectives

  • To learn about pathophysiology and clinical presentation of malignant SVC obstruction
  • To learn about techniques of SVC stenting
  • To learn about patient management and post-procedural care in patients with malignant SVC obstruction

 

Further Information

This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapter 2.2.1.3.3 Disease of the Superior and Inferior Vena Cava.

The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 1 European CME credit (ECMEC). The CME accreditation for this course will expire on February 18, 2023. A non-CME accredited version of the course will remain available until the new CME accredited course is published.

Upon purchase, access to complete and revisit the course is granted for an enrolment period of 90 days.

The CME certificate will be available in the myCIRSE area past the enrolment period if the course is completed before February 18, 2023.

Release date: February 2021